PhRMA Antibiotics Manufacturing Capability Review Requested By Thompson
Executive Summary
The Pharmaceutical Research & Manufacturers of America will submit a review of antibiotics manufacturing capability to HHS Secretary Tommy Thompson by early next week, President Alan Holmer told a press briefing Oct. 26.
You may also be interested in...
Anthrax Post-Exposure Drugs Need Extensive Marketing History – Draft Guidance
Drugs should have broad postmarketing experience before sponsors pursue an indication for post-exposure anthrax, a draft guidance from FDA's Center for Drug Evaluation & Research states
Anthrax Post-Exposure Drugs Need Extensive Marketing History – Draft Guidance
Drugs should have broad postmarketing experience before sponsors pursue an indication for post-exposure anthrax, a draft guidance from FDA's Center for Drug Evaluation & Research states
FDA Counter-Terrorism Will Take Precedence Over Rx Approvals In Crisis
Counter-terrorism activities will take priority over drug approvals at FDA in the event of another attack, Center for Drug Evaluation & Research Director Janet Woodcock, MD, said